Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Apple
AAPL
|
+$430M |
| 2 |
Microsoft
MSFT
|
+$312M |
| 3 |
Exxon Mobil
XOM
|
+$258M |
| 4 |
GE Aerospace
GE
|
+$224M |
| 5 |
Johnson & Johnson
JNJ
|
+$221M |
Top Sells
| 1 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$58.7M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$57.9M |
| 3 |
CB
CHUBB CORPORATION
CB
|
+$54.7M |
| 4 |
Stellantis
STLA
|
+$26.9M |
| 5 |
GMCR
KEURIG GREEN MTN INC
GMCR
|
+$20M |
Sector Composition
| 1 | Technology | 14.87% |
| 2 | Healthcare | 14.67% |
| 3 | Consumer Discretionary | 10.51% |
| 4 | Consumer Staples | 10.32% |
| 5 | Industrials | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QUOT
1926
DELISTED
Quotient Technology Inc
QUOT
| $958K | ﹤0.01% |
93,700
+23,400
| +33% | +$239K |
|
1927
Qualys
QLYS
$4.84B
| $956K | ﹤0.01% |
39,100
+7,300
| +23% | +$178K |
|
|
NTRI
1928
DELISTED
NutriSystem, Inc.
NTRI
| $955K | ﹤0.01% |
47,400
+8,900
| +23% | +$179K |
|
|
AMTG
1929
DELISTED
APOLLO RESIDENTIAL MTG INC COM STK
AMTG
| $955K | ﹤0.01% |
73,800
+29,600
| +67% | +$383K |
|
|
ATRI
1930
DELISTED
Atrion Corp
ATRI
| $953K | ﹤0.01% |
2,502
+902
| +56% | +$344K |
|
1931
Gogo Inc
GOGO
$1.29B
| $952K | ﹤0.01% |
89,400
+15,600
| +21% | +$166K |
|
1932
Frontline
FRO
$5.18B
| $949K | ﹤0.01% |
116,219
+22,086
| +23% | +$180K |
|
|
CPLA
1933
DELISTED
Capella Education Company
CPLA
| $945K | ﹤0.01% |
18,600
+3,400
| +22% | +$173K |
|
|
BGC
1934
DELISTED
General Cable Corporation
BGC
| $944K | ﹤0.01% |
80,100
+14,800
| +23% | +$174K |
|
1935
TriCo Bancshares
TCBK
$1.47B
| $941K | ﹤0.01% |
38,300
+6,200
| +19% | +$152K |
|
|
HTO
1936
H2O America Common Stock
HTO
$1.75B
| $939K | ﹤0.01% |
26,700
+4,600
| +21% | +$162K |
|
1937
Douglas Dynamics
PLOW
$756M
| $936K | ﹤0.01% |
42,100
+6,800
| +19% | +$151K |
|
1938
Universal Insurance Holdings
UVE
$721M
| $936K | ﹤0.01% |
54,400
+9,700
| +22% | +$167K |
|
1939
Inovio Pharmaceuticals
INO
$135M
| $935K | ﹤0.01% |
9,267
+1,734
| +23% | +$175K |
|
1940
Customers Bancorp
CUBI
$2.32B
| $932K | ﹤0.01% |
40,900
+7,800
| +24% | +$178K |
|
|
RAVN
1941
DELISTED
Raven Industries Inc
RAVN
| $929K | ﹤0.01% |
60,100
+11,300
| +23% | +$175K |
|
1942
Heron Therapeutics
HRTX
$195M
| $925K | ﹤0.01% |
50,400
+9,200
| +22% | +$169K |
|
1943
Lexicon Pharmaceuticals
LXRX
$411M
| $923K | ﹤0.01% |
79,614
+13,500
| +20% | +$157K |
|
|
SCLN
1944
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $922K | ﹤0.01% |
86,500
+14,200
| +20% | +$151K |
|
|
AHT
1945
Ashford Hospitality Trust
AHT
$38M
| $921K | ﹤0.01% |
152
+30
| +25% | +$182K |
|
|
ATW
1946
DELISTED
Atwood Oceanics
ATW
| $920K | ﹤0.01% |
103,850
+20,250
| +24% | +$179K |
|
|
ILG
1947
DELISTED
ILG, Inc Common Stock
ILG
| $918K | ﹤0.01% |
65,850
+13,150
| +25% | +$183K |
|
1948
Kelly Services Class A
KELYA
$480M
| $915K | ﹤0.01% |
49,500
+8,900
| +22% | +$165K |
|
|
TWOU
1949
DELISTED
2U, Inc.
TWOU
| $915K | ﹤0.01% |
1,400
+277
| +25% | +$181K |
|
|
UTEK
1950
DELISTED
Ultratech Inc.
UTEK
| $914K | ﹤0.01% |
43,400
+8,000
| +23% | +$168K |
|